Related Experiment Videos

Definition of streptozocin toxicity for primary lymphoidal tissues

Diabetes
|December 1, 1986
PubMed

Insights

Streptozocin, but not alloxan, temporarily impacted DNA synthesis and lymphocyte levels in mouse lymphoid tissues. This study highlights streptozocin

Area of Science:

  • Immunology
  • Endocrinology
  • Toxicology

Background:

  • Hyperglycemia is a hallmark of diabetes mellitus.
  • Streptozocin and alloxan are diabetogenic agents used to induce hyperglycemia in animal models.
  • Primary lymphoidal tissues, including bone marrow and thymus, are crucial for immune cell development.

Purpose of the Study:

  • To compare the effects of streptozocin and alloxan on primary lymphoidal tissues in BALB/c mice.
  • To investigate the impact of hyperglycemia induced by these agents on immune cell populations and function.

Main Methods:

  • Induction of hyperglycemia in BALB/c mice using streptozocin or alloxan.
  • Assessment of in situ and in vitro DNA synthesis in bone marrow and thymus.
  • Evaluation of circulating lymphocyte and thymocyte populations.

Main Results:

  • Streptozocin transiently inhibited DNA synthesis in bone marrow and thymus.
  • Streptozocin caused a temporary depletion of circulating lymphocytes and cortical thymocytes.
  • Alloxan did not exhibit these transient inhibitory effects on DNA synthesis or lymphocyte populations.
  • Streptozocin inhibited DNA synthesis in vitro in bone marrow and thymocyte cells.

Conclusions:

  • Streptozocin has a more pronounced and transient effect on primary lymphoidal tissues compared to alloxan.
  • Even subdiabetogenic doses of streptozocin can lead to significant depletion of lymphocytes and thymocytes.
  • These findings are relevant for understanding the immunomodulatory effects of diabetogenic agents.

Related Concept Videos